Liabilities, Current in USD of RECURSION PHARMACEUTICALS, INC. from Q4 2020 to Q3 2025

Taxonomy & unit: us-gaap: USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: Recursion Pharmaceuticals, Inc. quarterly Liabilities, Current history and change rate from Q4 2020 to Q3 2025.
Recursion Pharmaceuticals, Inc. Liabilities, Current for the quarter ending 30 Sep 2025 was $155M, a 42.4% increase year-over-year.

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Change (%)

RECURSION PHARMACEUTICALS, INC. Quarterly Liabilities, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2025	$155M	+$46.2M	+42.4%	30 Sep 2025	10-Q	05 Nov 2025
Q2 2025	$164M	+$77.9M	+90.5%	30 Jun 2025	10-Q	05 Aug 2025
Q1 2025	$142M	+$68.1M	+92.1%	31 Mar 2025	10-Q	05 May 2025
Q4 2024	$187M	+$94.3M	+101%	31 Dec 2024	10-Q	05 Nov 2025
Q3 2024	$109M	+$14.8M	+15.7%	30 Sep 2024	10-Q	06 Nov 2024
Q2 2024	$86.1M	-$27.9M	-24.5%	30 Jun 2024	10-Q	08 Aug 2024
Q1 2024	$73.9M	-$18.2M	-19.8%	31 Mar 2024	10-Q	09 May 2024
Q4 2023	$93.2M	-$7.09M	-7.08%	31 Dec 2023	10-K	28 Feb 2025
Q3 2023	$94.1M	+$11.1M	+13.3%	30 Sep 2023	10-Q	09 Nov 2023
Q2 2023	$114M	+$17.3M	+17.9%	30 Jun 2023	10-Q	08 Aug 2023
Q1 2023	$92.2M	+$6.45M	+7.52%	31 Mar 2023	10-Q	08 May 2023
Q4 2022	$100M	+$53.6M	+115%	31 Dec 2022	10-K	29 Feb 2024
Q3 2022	$83M	+$40.1M	+93.4%	30 Sep 2022	10-Q	08 Nov 2022
Q2 2022	$96.7M	+$67.1M	+227%	30 Jun 2022	10-Q	09 Aug 2022
Q1 2022	$85.7M	+$58.9M	+219%	31 Mar 2022	10-Q	10 May 2022
Q4 2021	$46.7M	+$23.6M	+102%	31 Dec 2021	10-K	27 Feb 2023
Q3 2021	$42.9M			30 Sep 2021	10-Q	10 Nov 2021
Q2 2021	$29.5M			30 Jun 2021	10-Q	13 Aug 2021
Q1 2021	$26.9M			31 Mar 2021	10-Q	12 May 2021
Q4 2020	$23.1M			31 Dec 2020	10-K	23 Mar 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.